CLOs on the Move

Center for Platelet Function Studies

www.platelets.org

 
Center for Platelet Function Studies is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

SI Paradigm

siParadigm is committed to create sustainable value by delivering outstanding services to our clients to help them meet the challenges of today’s changing healthcare environment. Our team is diligent in improving the quality of healthcare by providing the highest quality of laboratory testing and unmatched Turn-Around-Time (TAT). We will strive to meet these objectives by continuing to grow and adapt to consistently meet the needs of our patients, clients, and health system.

Finan Dermatopathology Lab PC

Finan Dermatopathology Lab PC is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Numed Inc

Numed Inc is a Crossroads, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Alliance for Microbicide Development

Alliance for Microbicide Development is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuvectra

Nuvectra™ is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson`s Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.